Vimarsana
Biggest News Aggregation in the World

Hank Safferstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hank Safferstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hank Safferstein Today - Breaking & Trending Today

Cognition Therapeutics Receives Patent For Alzheimer's Disease Drug - Vimarsana News

Cognition Therapeutics Receives Patent For Alzheimer's Disease Drug

Alzheimer’s disease is a debilitating neurodegenerative disease and the most common form of dementia. Symptoms include irritability, confusion, mood swings, language difficulties and memory loss. Cognitive dysfunction becomes more pronounced as the disease progresses, leading to the loss of bodily functions and eventually death.

Generian Pharmaceuticals to Participate in the Cowen 43rd Annual Healthcare Conference - Vimarsana News

Generian Pharmaceuticals to Participate in the Cowen 43rd Annual Healthcare Conference

/PRNewswire/ -- Generian Pharmaceuticals, Inc., ("Generian"), a biopharmaceutical company discovering and developing orally bioavailable small molecule...

Generian Achieves First Milestones in Mitobridge Collaboration - Vimarsana News

Generian Achieves First Milestones in Mitobridge Collaboration

/PRNewswire/ -- Generian Pharmaceuticals, Inc., a preclinical biopharmaceutical company discovering and developing first-in-class orally bioavailable small...

Generian, Astellas to develop molecules for undruggable therapeutic - Vimarsana News

Generian, Astellas to develop molecules for undruggable therapeutic

Generian has signed a collaboration and exclusive license agreement with Astellas Pharma to develop new small molecules for undruggable therapeutic targets.

Generian and Astellas Enter into Collaboration and Exclusive License Agreement to Discover and Develop Novel Small Molecules For Undruggable Targets - Vimarsana News

Generian and Astellas Enter into Collaboration and Exclusive License Agreement to Discover and Develop Novel Small Molecules For Undruggable Targets

/PRNewswire/ -- Generian Pharmaceuticals, Inc. ("Generian") and Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma Inc.) announced today that they...